OBJECTIVE: Studies summarizing the outcome of first trimester septated cystic hygroma are generally based on small studies or from multiple centers with limited ascertainment. We reviewed the natural history of a large cohort of such cases from a single tertiary referral center, with the aim being to establish contemporary outcome data, particularly in the setting of normal karyotype. STUDY DESIGN: A retrospective cohort study from 2007 to 2017 was conducted at a single tertiary center. Data was analyzed from a prospectively-collated fetal anomaly database. Search terms were 'increased nuchal translucency' , 'cystic hygroma' and 'septated cystic hygroma' . All cases were confirmed to have NT >3mm with septations. Cases of simple increased nuchal translucency without septations were excluded. RESULTS: During the study period, over 110,000 pregnancies were delivered at our center, resulting in 410 cases of first trimester septated cystic hygroma. Pregnancy outcome was obtained in 99% (405/ 410) of cases, and detailed pathology outcome in 92% (378/410). Table 1 summarizes the underlying pathology diagnosed. A total of 87% (351/405) opted for invasive prenatal testing, and postnatal chromosome status was established in a further 27 cases. A total of 61% (230/378) had abnormal chromosomal status. Of the 39% (148/378) with normal chromosomes, only 13% (19/148) had a significant structural fetal abnormality, which included 7 cardiac and 12 non-cardiac abnormalities. Table 2 summarizes the pregnancy outcome associated with cystic hygroma. Overall, perinatal loss was 62% (253/405). The total survival rate in the setting of euploid cystic hygroma without structural abnormality was 77% (99/129). CONCLUSION: Counselling regarding outcomes in the setting of first trimester septated cystic hygroma initially focuses on the strong likelihood of an abnormal karyotype, which occurs in 61% of cases. However, once fetal chromosomal abnormality is excluded, our results demonstrate only a 13% incidence of major structural fetal abnormality, which appears significantly less than previously reported. Normal fetuses have a 77% survival rate. These data represent the largest single center study of first trimester cystic hygroma with complete outcome data and therefore will be useful for contemporary patient counselling. Such counselling can be more positive than previously expected, once chromosomal abnormality is first excluded. Ben-Gurion University of the Negev, Faculty of Health Sciences, Beer Sheva, Negev, Israel OBJECTIVE: Amniotic fluid abnormalities are often associated with short-term adverse pregnancy outcomes, some of which are endocrine related. Little is known about long-term endocrine complications in offspring following pregnancies with isolated abnormal amniotic fluid volume. We sought to assess whether in-utero exposure to amniotic fluid abnormalities increases the risk of longterm endocrine morbidity in the offspring. STUDY DESIGN: In a population based cohort study, the incidence of endocrine disorders was compared between singletons exposed and non-exposed to oligohydramnios (amniotic fluid index [AFI] <5 cm) or polyhydramnios (AFI>24 cm). Endocrine morbidity was assessed up to the age of 18 years according to a predefined set of ICD-9 codes associated with hospitalization of the offspring. Deliveries occurred between the years 1991-2014 in a regional tertiary medical center. Multiple gestations, perinatal deaths, mothers with gestational and pre-gestational diabetes, chronic or gestational hypertensive disorders, placental abruption, preterm and term premature ruptures of membranes (PROM), lack of prenatal care, and children with congenital malformations, chromosomal abnormalities and RH isoimmunisation, were excluded from the study.
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